Description

Microarray Panel:Liver cancerNo. of samples59No. of patients59Core diameter2.0 mmFormat:Formalin FixedSection thickness 4 micrometer Core# No. Age Sex Organ Diagnosis pTNM Stage No. of CSN4# Tissuetype Image 1 53 F Skin metastatic hepatocellular carcinoma TxNxM1 IVB . 6 " class="fd_image"> 2 57 M Liver hepatocellular carcinoma T3aN0M0 IIIA 104 6 " class="fd_image"> 3 41 M Liver hepatocellular carcinoma T3aN0M0 IIIA . 6 " class="fd_image"> 4 45 M Skin metastatic hepatocellular carcinoma TxNxM1 IVB . 6 " class="fd_image"> 5 54 F Chest wall metastatic hepatocellular carcinoma TxNxM1 IVB . 6 " class="fd_image"> 6 40 M Lumbar vertebra metastatic hepatocellular carcinoma TxNxM1 IVB . 6 " class="fd_image"> 7 52 M Liver hepatocellular carcinoma T3aN0M0 IIIA 112 6 " class="fd_image"> 8 43 M Bile duct hepatocellular carcinoma T4NxM0 IIIC . 6 " class="fd_image"> 9 51 M Colon metastatic hepatocellular carcinoma TxNxM1 IVB . 6 " class="fd_image"> 10 49 M Bile duct hepatocellular carcinoma T4NxM0 IIIC . 6 " class="fd_image"> 11 56 M Liver hepatocellular carcinoma T1N0M0 I . 6 " class="fd_image"> 12 56 F Lung metastatic hepatocellular carcinoma TxNxM1 IVB . 6 " class="fd_image"> 13 40 M Lymph node metastatic hepatocellular carcinoma T3aN1M0 IVA . 6 " class="fd_image"> 14 37 M Liver hepatocellular carcinoma T4NxM1 IVB 131 6 " class="fd_image"> 15 75 M Liver hepatocellular carcinoma T2N0M0 II 132 6 " class="fd_image"> 16 37 M Neck metastatic hepatocellular carcinoma TxNxM1 IVB . 6 " class="fd_image"> 17 32 M Liver combined hepatocellular carcinoma & cholangiocarcinoma T3aN0M0 IIIA 133 6 " class="fd_image"> 18 50 M Femur metastatic hepatocellular carcinoma TxNxM1 IVB . 6 " class="fd_image"> 19 57 M Liver hepatocellular carcinoma T3aN0M0 IIIA 134 6 " class="fd_image"> 20 62 M Lung metastatic hepatocellular carcinoma TxNxM1 IVB . 6 " class="fd_image"> 21 61 M Lung metastatic hepatocellular carcinoma TxNxM1 IVB . 6 " class="fd_image"> 22 65 M Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I 135 6 " class="fd_image"> 23 64 M Liver hepatocellular carcinoma, moderately differentiated T3bN0M0 IIIB . 6 " class="fd_image"> 24 65 M Liver hepatocellular carcinoma, poorly differentiated T3aN0M0 IIIA 137 6 " class="fd_image"> 25 72 M Liver hepatocellular carcinoma, well differentiated & poorly differentiated T2N0M0 II 138 6 " class="fd_image"> 26 58 F Liver hepatocellular carcinoma, well differentiated T2N0M0 II 139 6 " class="fd_image"> 27 52 M Liver hepatocellular carcinoma, well differentiated T2N0M0 II 140 6 " class="fd_image"> 28 40 M Liver hepatocellular carcinoma, moderately differentiated T2N0M0 II 141 6 " class="fd_image"> 29 53 F Liver hepatocellular carcinoma, moderately differentiated T3bN0M0 IIIB 142 6 " class="fd_image"> 30 67 M Liver hepatocellular carcinoma, moderately differentiated T2N0M0 II 143 6 " class="fd_image"> 31 58 F Liver hepatocellular carcinoma, moderately differentiated T3aN0M0 IIIA . 6 " class="fd_image"> 32 20 M Liver hepatocellular carcinoma, well differentiated T4N0M0 IIIC . 6 " class="fd_image"> 33 48 M Liver hepatocellular carcinoma, moderately differentiated T2N0M0 II . 6 " class="fd_image"> 34 47 M Liver hepatocellular carcinoma T1N0M0 I 144 6 " class="fd_image"> 35 35 M Omentum metastatic hepatocellular carcinoma TxNxM1 IV . 6 " class="fd_image"> 36 69 F Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I . 6 " class="fd_image"> 37 46 M Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I . 6 " class="fd_image"> 38 63 F Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I 146 6 " class="fd_image"> 39 60 F Liver hepatocellular carcinoma, poorly differentiated T1N0M0 I 147 6 " class="fd_image"> 40 62 M Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I 148 6 " class="fd_image"> 41 52 M Liver hepatocellular carcinoma, moderately differentiated T2N0M0 II . 6 " class="fd_image"> 42 66 F Liver hepatocellular carcinoma, moderately differentiated T2N0M0 II 149 6 " class="fd_image"> 43 65 F Liver hepatocellular carcinoma, well differentiated T1N0M0 I 150 6 " class="fd_image"> 44 64 M Liver hepatocellular carcinoma, moderately differentiated T3bN0M0 IIIB . 6 " class="fd_image"> 45 59 M Liver hepatocellular carcinoma, poorly differentiated T3bN0M0 IIIB . 6 " class="fd_image"> 46 64 M Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I 151 6 " class="fd_image"> 47 54 M Liver hepatocellular carcinoma, moderately differentiated T3bN0M0 IIIB 152 6 " class="fd_image"> 48 65 F Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I 153 6 " class="fd_image"> 49 60 M Adrenal gland metastatic hepatocellular carcinoma TxNxM1 IVB . 6 " class="fd_image"> 50 44 M Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I . 6 " class="fd_image"> 51 41 M Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I . 6 " class="fd_image"> 52 51 M Liver hepatocellular carcinoma T1N0M0 I 154 6 " class="fd_image"> 53 55 M Liver hepatocellular carcinoma, well differentiated T1N0M0 I . 6 " class="fd_image"> 54 57 F Liver hepatocellular carcinoma, well differentiated T1N0M0 I 156 6 " class="fd_image"> 55 57 M Liver hepatocellular carcinoma, moderately differentiated T3bN0M0 IIIB 157 6 " class="fd_image"> 56 43 M Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I . 6 " class="fd_image"> 57 50 M Liver hepatocellular carcinoma, poorly differentiated T1N0M0 I 158 6 " class="fd_image"> 58 43 M Liver hepatocellular carcinoma, moderately differentiated T1N0M0 I 159 6 " alt="" class="fd_image"> 59 60 F Liver hepatocellular carcinoma, poorly differentiated T4N0M0 IIIC . 6 " alt=" " class="fd_image"> 60 . . Carbon . . . . . " alt="" class="fd_image">

Publications

ReadPublications using NBP2-30271.

Novus Biologicals北京代理，Novus Biologicals中国代理，Novus Biologicals上海代理，Novus Biologicals公司，Novus Biologicals 【详细说明】  Novus Biologicals北京代理，Novus Biologicals中国代理，Novus Biologicals上海代理，Novus Biologicals公司，Novus Biologicals 上海普迈生物科技有限公司签约代理      欢迎下载下面的资料以了解此产品的相关信息！预询产品订购信息  上海普迈生物致力于提供zui高质量的产品和服务组织形态学研究与竞争力的产品 产品和服务,有相关产品的问题请直接 期货每周下午5点前发定单，正常到上海时间为3-4周 现市区2天内送到，外地以快递为准 敬请关注！ ：   :www.pumaibio.com :pumaibio :（直接客户） （经销商） 促销etonbio、polysciences、Mattek、trevigen、Chromogenix、cyguns、IrvineScientific、Innovative Cell Technologies、enzo、novus、immunochemistry、eylabs、Polyplus、NIBSC、ALZET、hitobiotec、sutter instrument、mirus、StressMarq、Avanti、jena bioscience、Neuro Probe、tedpella、avanti、Rockland、CAYMAN、transgenomic、BioLegend、ambion、omicronbio、 Assaybiotech、chondrex、lc?laboratories、cosmobio、megazyme、NeoMarkers、BTI、eylabs、berryassoc、cellagentech、TOCRIS、Relia Tech、SouthernBiotech、Biosearch technology、Lumiprobe、StemCells?Inc、biovendor、NORGEN、alomone、jena?bioscience、Gracebio、Eurogentec、Gelcompany?、invitrogen、gene?bridges、MRC-Holland、laysanbio